CYTK
Price
$40.54
Change
+$0.29 (+0.72%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
4.77B
28 days until earnings call
TRAW
Price
$2.13
Change
-$0.19 (-8.19%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
10.72M
Ad is loading...

CYTK vs TRAW

Header iconCYTK vs TRAW Comparison
Open Charts CYTK vs TRAWBanner chart's image
Cytokinetics
Price$40.54
Change+$0.29 (+0.72%)
Volume$55.05K
Capitalization4.77B
Traws Pharma
Price$2.13
Change-$0.19 (-8.19%)
Volume$1.39K
Capitalization10.72M
CYTK vs TRAW Comparison Chart
Loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYTK vs. TRAW commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYTK is a Hold and TRAW is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CYTK: $40.25 vs. TRAW: $2.32)
Brand notoriety: CYTK and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYTK: 251% vs. TRAW: 96%
Market capitalization -- CYTK: $4.8B vs. TRAW: $10.72M
CYTK [@Biotechnology] is valued at $4.8B. TRAW’s [@Biotechnology] market capitalization is $10.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYTK’s FA Score shows that 1 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • CYTK’s FA Score: 1 green, 4 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than TRAW.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYTK’s TA Score shows that 4 TA indicator(s) are bullish while TRAW’s TA Score has 5 bullish TA indicator(s).

  • CYTK’s TA Score: 4 bullish, 6 bearish.
  • TRAW’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, TRAW is a better buy in the short-term than CYTK.

Price Growth

CYTK (@Biotechnology) experienced а -7.75% price change this week, while TRAW (@Biotechnology) price change was -8.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

CYTK is expected to report earnings on May 01, 2025.

TRAW is expected to report earnings on Nov 14, 2024.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($4.77B) has a higher market cap than TRAW($10.7M). CYTK YTD gains are higher at: -14.435 vs. TRAW (-73.874). TRAW has higher annual earnings (EBITDA): -24.08M vs. CYTK (-493.48M). CYTK has more cash in the bank: 1.08B vs. TRAW (5.41M). CYTK has higher revenues than TRAW: CYTK (18.5M) vs TRAW (226K).
CYTKTRAWCYTK / TRAW
Capitalization4.77B10.7M44,542%
EBITDA-493.48M-24.08M2,049%
Gain YTD-14.435-73.87420%
P/E RatioN/AN/A-
Revenue18.5M226K8,186%
Total Cash1.08B5.41M19,889%
Total Debt789MN/A-
FUNDAMENTALS RATINGS
CYTK vs TRAW: Fundamental Ratings
CYTK
TRAW
OUTLOOK RATING
1..100
8274
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
65100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
8797
P/E GROWTH RATING
1..100
1100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (33) in the Biotechnology industry is significantly better than the same rating for CYTK (100). This means that TRAW’s stock grew significantly faster than CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (65) in the Biotechnology industry is somewhat better than the same rating for TRAW (100). This means that CYTK’s stock grew somewhat faster than TRAW’s over the last 12 months.

CYTK's SMR Rating (100) in the Biotechnology industry is in the same range as TRAW (100). This means that CYTK’s stock grew similarly to TRAW’s over the last 12 months.

CYTK's Price Growth Rating (87) in the Biotechnology industry is in the same range as TRAW (97). This means that CYTK’s stock grew similarly to TRAW’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is significantly better than the same rating for TRAW (100). This means that CYTK’s stock grew significantly faster than TRAW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CYTKTRAW
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 28 days ago
78%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HAYW14.060.39
+2.85%
Hayward Holdings
TMCI8.320.17
+2.09%
Treace Medical Concepts
FSLR129.822.25
+1.76%
First Solar
HYZN0.64N/A
N/A
Hyzon Motors Inc
CLWT1.11-0.07
-6.06%
Euro Tech Holdings Company Limited